Clinical Trials Logo
  1. Home
  2. Tobacco Use Disorder
  3. NCT02342327
  4. Details
NCT02342327 Clinical Trial

Smoking Cessation in Menthol Flavored Cigarette Smokers

Tobacco Use Disorder Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT02342327
Other study ID # 1406M51364
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 28, 2014
Est. completion date July 11, 2018

Study information
Verified date April 2021
Source University of Minnesota
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine if in smokers of menthol cigarettes, switching to non-menthol cigarettes prior to a cessation attempt results in greater cessation success than attempting to quit without first switching

Recruitment information / eligibility
Status Completed
Enrollment 122
Est. completion date July 11, 2018
Est. primary completion date July 11, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years to 64 Years
Eligibility Inclusion Criteria: - Self identify as African American - smoke primarily menthol cigarettes - be between the ages of 18 and 64 - smoke a minimum number of cigarettes per day - express an interest in quitting smoking Exclusion Criteria: - current unstable medical / psychiatric condition - regular use any form of nicotine or tobacco other than cigarettes - are pregnant or breast feeding The investigators will evaluate if there are other reasons why someone may not be eligible to participate

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• switch to non-menthol cigarettes prior to cessation attempt

• continue smoking menthol cigarettes prior to cessation attempt

Locations
Country Name City State
United States Clinical and Translational Sciences Institute Minneapolis Minnesota

Sponsors (1)
Lead Sponsor Collaborator
University of Minnesota

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Time to Lapse Time from smoking cessation until first lapse (i.e. a cigarette is smoked) 6 months
Secondary Time to Relapse Days from the quit attempt until the first of seven consecutive smoking days 6 months
See also
  Status Clinical Trial Phase
Withdrawn NCT02432066 - Effects of GTS-21 on Smoking Behavior and Neurocognitive Functions Phase 2
Completed NCT03960138 - Examining the Effects of Neural Stimulation on Inhibitory Control and Cigarette Smoking N/A
Recruiting NCT05030272 - Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings N/A
Completed NCT04646668 - Comparative Abuse Liability Among African American and White Smokers N/A
Completed NCT02560324 - Effect of Ramelteon on Smoking Abstinence Phase 2
Completed NCT02347605 - Medicinal Nicotine for Preventing Cue Induced Craving N/A
Completed NCT01442753 - Family-Skills Training to Prevent Tobacco and Other Substance Use in Latino Youth N/A
Completed NCT01570595 - Positively Smoke Free on the Web (PSFW) for Smokers Living With HIV Phase 1/Phase 2
Completed NCT01625767 - Tobacco Approach Avoidance Training for Adolescent Smokers-1 Phase 2
Terminated NCT01800500 - Interest in Smokeless Tobacco Product as a Substitution for Cigarettes in Current Smokers N/A
Completed NCT01428310 - Study to Evaluate the Safety and Efficacy of Dietary Supplement Anatabloc in Reducing Daily Smokers' Urge to Smoke Phase 1
Active, not recruiting NCT01539525 - Screening to Augment Referral to Treatment- Project START Phase 2
Completed NCT00967005 - N-Acetyl Cysteine Plus Behavioral Therapy for Nicotine Dependent Pathological Gamblers Phase 2
Completed NCT01337817 - A Pilot Study to Evaluate the Efficacy and Safety of Ariva® Silver Wintergreen in Healthy Smokers Phase 1
Active, not recruiting NCT00751660 - Screening Methods in Finding Lung Cancer Early in Current or Former Smokers N/A
Completed NCT00790569 - Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking N/A
Completed NCT00664261 - Clinical Effort Against Secondhand Smoke (CEASE) Program or Standard Care in Helping Parents Stop Smoking N/A
Completed NCT00158145 - Assessing the Variability Over Time of Tobacco Carcinogen Biomarkers in Smokers - 2 Phase 2
Completed NCT00158158 - Effectiveness of Reducing Smoking in Facilitating Smoking Cessation in Adolescents - 2 Phase 2/Phase 3
Completed NCT00218179 - Assessing the Link Between Smoke Carcinogen Biomarkers and Lung Cancer Risk - 1 N/A